Bristol Myers Squibb

Company Overview

Bristol-Myers Squibb Company is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are Apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis ; pomalidomide (Pomalyst/Imnovid), an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma ; ipilimumab (Yervoy), to treat cancer ; and luspatercept (Reblozyl) for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States.

Industry

Pharmaceuticals

Financial Summary

Revenue (TTM)

$46.16B

Net Income (TTM)

$6.33B

Total Assets

$95.16B

Total Debt

$39.53B

Total Equity

$29.43B

Market Cap

-

Valuation Metrics

P/E Ratio

-

P/B Ratio

-

Profit Margin

13.71%

ROE

21.50%

ROA

6.65%

Dividend Yield

-

More Health Care Stocks